Abstract
Results from a study that assessed whether individuals with ASD exhibit abnormal in vivo brain expression of the neuroimmune marker translocator protein (TSPO) using [11C]PBR28 positron emission tomography (PET) imaging will be presented.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Paper Title
Journal
Date
